Sip, S.; Paczkowska-Walendowska, M.; Rosiak, N.; Miklaszewski, A.; Grabańska-Martyńska, K.; Samarzewska, K.; Cielecka-Piontek, J.
Chitosan as Valuable Excipient for Oral and Topical Carvedilol Delivery Systems. Pharmaceuticals 2021, 14, 712.
https://doi.org/10.3390/ph14080712
AMA Style
Sip S, Paczkowska-Walendowska M, Rosiak N, Miklaszewski A, Grabańska-Martyńska K, Samarzewska K, Cielecka-Piontek J.
Chitosan as Valuable Excipient for Oral and Topical Carvedilol Delivery Systems. Pharmaceuticals. 2021; 14(8):712.
https://doi.org/10.3390/ph14080712
Chicago/Turabian Style
Sip, Szymon, Magdalena Paczkowska-Walendowska, Natalia Rosiak, Andrzej Miklaszewski, Katarzyna Grabańska-Martyńska, Karolina Samarzewska, and Judyta Cielecka-Piontek.
2021. "Chitosan as Valuable Excipient for Oral and Topical Carvedilol Delivery Systems" Pharmaceuticals 14, no. 8: 712.
https://doi.org/10.3390/ph14080712
APA Style
Sip, S., Paczkowska-Walendowska, M., Rosiak, N., Miklaszewski, A., Grabańska-Martyńska, K., Samarzewska, K., & Cielecka-Piontek, J.
(2021). Chitosan as Valuable Excipient for Oral and Topical Carvedilol Delivery Systems. Pharmaceuticals, 14(8), 712.
https://doi.org/10.3390/ph14080712